BioNexus Gene Lab Corp. has appointed Ms. Chong Set Fui (Angeline) as the new Chief Financial Officer and Principal Financial Officer, effective June 17, 2025. Ms. Chong brings over 25 years of financial leadership experience, previously serving as CFO of Avillion Berhad. She will also serve as CFO of the company's subsidiary, MRNA Scientific Sdn. Bhd. Concurrently, Mr. Su-Leng Tan Lee has stepped down from his role as acting CFO and Principal Financial Officer.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-004754), on June 23, 2025, and is solely responsible for the information contained therein.